|
|
 |
|
Viewing report
|
|
|
|
Prescribing Influences: Multiple Sclerosis - Therapies that reverse neuronal damage are most sought after
Datamonitor, Aug 2011, Pages: 61
Introduction
Datamonitor conducted a survey of neurologists to ascertain the perceived level of unmet need in multiple sclerosis and to assess which factors have the greatest influence on prescribing decisions. The analysis is designed to provide an understanding of the opportunities in the market and to support the successful competitive positioning of multiple sclerosis brands.
Features and benefits
- Understand the key unmet needs in multiple sclerosis treatment and their relative importance, as rated by prescribing neurologists.
- Understand the key drivers of brand choice in multiple sclerosis management and their relative importance, as rated by prescribing neurologists.
- Understand the patient care pathway, and how it can be influenced to drive ethical drug usage.
- Assess the marketing strategies of the leading companies in the multiple sclerosis market.
- Gauge the attributes of a drug that most influence physician prescribing behavior.
Highlights
- The opportunity to stop or reverse multiple sclerosis is huge, as current drugs only slow the course of the disease. Development of effective therapies to treat progressive cases is considered the second most important unmet need by interviewed neurologists.
- There are no official international guidelines for the chronic disease-modifying treatment of multiple sclerosis. As the number of disease-modifying treatment options increase over the next decade Datamonitor anticipates the development of official multiple sclerosis clinical guidelines and treatment algorithms will become a high priority.
- Surveyed neurologists rated slowing disease progression and reduction in relapses as the leading factors to consider when deciding upon treatment. This is unsurprising, as with no cure available, prevention of disease progression aimed at enhancing the quality of life for sufferers is the physician’s priority.
Your key questions answered
- What are the most important unmet needs in multiple sclerosis treatment?
- How do different attributes of a drug’s profile influence neurologists’ prescribing decisions?
- How do multiple sclerosis patients progress through the care pathway and what do the treatment guidelines recommend?
- Which marketing strategies are most widely employed and have been the most successful?
|
|
|
|
